St. Louis, Missouri 63110


Purpose:

To determine the pharmacokinetics of methadone in children and adults with SCD who are experiencing a painful episode.


Criteria:

Inclusion Criteria: - Greater than or equal to 7 years and less than or equal to 40 years - Confirmed diagnosis of any form of sickle cell disease, including sickle cell anemia, sickle-hemoglobin C disease, and sickle-B thalassemia - Currently experiencing a vaso-occlusive episode (VOE), defined as acute pain in the extremities - Admitted to the inpatient unit for further treatment - Started on morphine patient controlled analgesia and infusion for pain management Exclusion Criteria: - Diagnosis of acute chest syndrome - New focal neurologic findings or clinical concern of stroke - Aplastic crisis with hemoglobin 2 g/dl below steady-state value - Allergy to morphine or methadone - Any other medical condition that the attending physician deems to be a contraindication to therapy - Liver or renal insufficiency or failure, and congestive heart failure


NCT ID:

NCT00761085


Primary Contact:

Principal Investigator
Evan D Kharasch, MD, PhD
Washington University School of Medicine


Backup Contact:

N/A


Location Contact:

St. Louis, Missouri 63110
United States

Evan D Kharasch, MD, PhD
Phone: 314-362-7551
Email: kharasch@wustl.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.